MacroGenics to Participate in Upcoming Investor Conference

ROCKVILLE, MD, Feb. 02, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer,

Related Keywords

Rockville ,New York ,United States ,Jim Karrels ,Scott Koenig ,Macrogenics Inc ,Nasdaq ,Macrogenics The Company ,Healthcare Talks ,Annual Biotechnology Conference ,Macrogenic President ,Investor Relations ,Senior Vice President ,